AI assistant
Sending…
BIO-TECHNE Corp — Director's Dealing 2012
Nov 28, 2012
30718_dirs_2012-11-28_3b4a08a9-f37c-419e-9b9b-8511508587a1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2012-10-26
Reporting Person: OCONNELL HOWARD V (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-10-26 | Common Stock | M | 5000 | $37.1 | Acquired | 95639 | Indirect |
| 2012-10-26 | Common Stock | S | 8000 | $71.81 | Disposed | 87639 | Indirect |
| 2012-10-27 | Common Stock | G | 20000 | $71.65 | Disposed | 67639 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-10-26 | Stock Option | $37.1 | M | 5000 | Disposed | 2014-10-20 | Common Stock (5000) | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $66.9 | 2022-10-24 | Common Stock (5000) | 5000 | Direct |
| Stock Option | $70.35 | 2021-10-26 | Common Stock (5000) | 5000 | Direct |
| Stock Option | $61.46 | 2020-10-27 | Common Stock (5000) | 5000 | Direct |
| Stock Option | $63.03 | 2019-10-28 | Common Stock (5000) | 5000 | Indirect |
| Stock Option | $65.47 | 2018-10-22 | Common Stock (5000) | 5000 | Indirect |
| Stock Option | $66.59 | 2017-10-24 | Common Stock (5000) | 5000 | Indirect |
| Stock Option | $56.17 | 2016-10-25 | Common Stock (5000) | 5000 | Indirect |
| Stock Option | $54.68 | 2015-10-26 | Common Stock (5000) | 5000 | Indirect |
More from BIO-TECHNE Corp
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 19
Board/Management Information
2026
Feb 11
Director's Dealing
2026
Feb 5
Interim / Quarterly Report
2026
Feb 4